Company: OXBRW
Filing Date: 2025-02-26
Form Type: 424B5
Source: 0001493152-25-008248
Chunk: 21

Company: OXBRIDGE RE HOLDINGS Ltd
Filing Date: 2025-02-26
Form: 424B5
Chunk 21
---
 IS FOR GENERAL INFORMATION PURPOSES ONLY. IT IS NOT TAX ADVICE. EACH PROSPECTIVE INVESTOR SHOULD CONSULT ITS OWN TAX ADVISOR REGARDING THE PARTICULAR U.S. FEDERAL, STATE, LOCAL AND FOREIGN TAX CONSEQUENCES OF PURCHASING, HOLDING AND DISPOSING OF OUR ORDINARY SHARES, INCLUDING THE CONSEQUENCES OF ANY PROPOSED CHANGE IN APPLICABLE LAWS.

| S-10 |

<div align='center'>DESCRIPTION OF SECURITIES WE ARE OFFERING</div>

We are offering 705,884 ordinary shares (the “ordinary shares”) to certain investors pursuant to this prospectus supplement and the accompanying prospectus.

Ordinary Shares

The material terms and provisions of our ordinary shares are described under the caption “Description of Ordinary Shares” in this prospectus.

| S-11 |

<div align='center'>PLAN OF DISTRIBUTION</div>

Pursuant to a placement agency agreement between us and Maxim Group LLC (“Maxim” or the “placement agent”) we have engaged Maxim as our exclusive placement agent to solicit offers to purchase the ordinary shares in this offering. The placement agent is not purchasing or selling any of the securities we are offering, and it is not required to arrange the purchase or sale of any specific number of ordinary shares or dollar amount, but it has agreed to use commercially reasonable efforts to arrange for the sale of the ordinary shares. The placement agent may retain sub-agents and selected dealers in connection with this offering.

The placement agent proposes to arrange for the sale of the ordinary shares we are offering pursuant to this prospectus supplement and the accompanying prospectus to one or more investors through securities purchase agreements directly between the purchasers and us. All of the ordinary shares will be sold at the same price and, we expect, at a single closing. We established the price following negotiations with prospective investors and with reference to the prevailing market price of our ordinary shares, recent trends in such price and other factors. It is possible that not all of the ordinary shares we are offering pursuant to this prospectus supplement and the accompanying prospectus will be sold at the closing, in which case our net proceeds would be reduced. We anticipate that the sale of the ordinary shares will be completed on the date indicated on the cover page of this prospectus supplement, subject to customary closing conditions. On the closing date, the following will occur:

| ● | we                                                                                                                      
 will receive funds in the amount of the aggregate purchase price;                                                       |
| ● | Maxim,